• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: VALERITAS, LLC V-GO DISPOSABLE INSULIN DELIVERY DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

VALERITAS, LLC V-GO DISPOSABLE INSULIN DELIVERY DEVICE Back to Search Results
Model Number V-GO 40
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Fall (1848); Hyperglycemia (1905); Diabetic Ketoacidosis (2364); Confusion/ Disorientation (2553)
Event Date 02/21/2014
Event Type  Injury  
Event Description
Pt with type 2 diabetes reported high bg values while wearing v-go insulin delivery device to valeritas call center.Pt reports that while on v-go 40 he was hospitalized on (b)(6) 2014 with dka.As noted by pt's fiancee, on the afternoon of (b)(6) 2014 pt was acting "delirious, confused, falling into things".She then measured his bg at "hi".The fiancee contacted his hcp who recommended 6 clicks (12u) bolus.When bg did not decrease hsp recommended that pt be taken to emergency department (ed).Pt reports the following treatment during hospitalization: at ed, pt bg measured 529 mg/dl; pt was admitted overnight and bg was managed via insulin injection; per patient he was released the next day with bg of approximately 400mg/dl.Pt and fiancee are confident that they applied and used the b-go correctly.Pt confirms that "insulin was going in".Pt denies any current or recent illness, infection, change in diet or exercise or other factors which could cause or contribute to hyperglycemia.Pt confirms that he did deliver his bolus dose of 6 clicks per meal.There is no suggestion of device malfunction.
 
Manufacturer Narrative
Patient stated that he had been using the product for one day only.Mdr (is being submitted per our procedure since: patient required medical intervention and was hospitalized with diabetic ketoacidosis (dka).No device was returned for investigation so cannot determine whether the hyperglycemia was due to the device not working correctly or due to user error.
 
Manufacturer Narrative
Block b3- date corrected.Block b4-date corrected.Block e1- initial reporter corrected.Block e2- health professional - no checked.Block e3- non healthcare professional.Block g4- date provided.Block g7- follow up #1.Block h1- serious injury.Block h2- correction checked.Block h6 - patient, device, method, results and conclusion codes corrected.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
V-GO DISPOSABLE INSULIN DELIVERY DEVICE
Type of Device
V-GO
Manufacturer (Section D)
VALERITAS, LLC
800 boston turnpike
suite 100
bridgewater NJ 08807 2597
MDR Report Key3678623
MDR Text Key4290831
Report Number1226572-2014-00002
Device Sequence Number1
Product Code KZE
Combination Product (y/n)N
PMA/PMN Number
K103825
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer,consumer
Type of Report Initial,Followup
Report Date 02/24/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/11/2014
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date08/01/2014
Device Model NumberV-GO 40
Device Lot NumberFG213117
Was Device Available for Evaluation? No
Date Manufacturer Received02/24/2014
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
Patient Age58 YR
Patient Weight102
-
-